ADAM CONLIN: Open Payments
NPI 1538528336 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,303 in 60 payments from 16 companies in 2025. Trend: 2023 $1,085 · 2024 $1,294 · 2025 $1,303
Food & beverage: $1,303
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $352 |
| AstraZeneca Pharmaceuticals LP | 7 | $126 |
| ANI Pharmaceuticals, Inc. | 4 | $113 |
| Calliditas Therapeutics US Inc. | 5 | $106 |
| Amgen Inc. | 4 | $100 |
| Mallinckrodt Hospital Products Inc. | 5 | $98 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69 |
| Apellis Pharmaceuticals, Inc. | 2 | $50 |
| AKEBIA THERAPEUTICS INC | 2 | $47 |
Products named: Fabhalta, PURIFIED CORTROPHIN GEL, TARPEYO, JYNARQUE, Kerendia, JARDIANCE, TERLIVAZ, KRYSTEXXA.
Industry payments across WI — which companies pay providers there.
